Cefaclor: in vitro spectrum of activity and beta-lactamase stability.
about
Antibiotics for emerging pathogensAutobac I procedure to assess susceptibility to Cefaclor[Experience with cefaclor in the treatment of ear, nose and throat infections. Indications for cefaclor therapy (author's transl)]Molecular basis of the efficacy of cefaclor against Haemophilus influenzae.In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibioticIn vitro investigation of BK-218, a new oral and parenteral cephalosporin.In vitro activities of LY163892, cefaclor, and cefuroximeComparative kill and growth rates determined with cefdinir and cefaclor and with Streptococcus pneumoniae and beta-lactamase-producing Haemophilus influenzae.Penetration of cefaclor into bronchial mucosaNasopharyngeal carriage and antibiotic resistance of Haemophilus influenzae in healthy children.Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester.In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral beta-lactam antibioticsIn vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin.Comparative antibacterial activity of an arylglycyl oral cephalosporin, LY164846.In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic.Susceptibility of Haemophilus influenzae type b to cefaclor and influence of inoculum size.Antibiotic use in cystic fibrosis. 1984.
P2860
Q29615377-36D20E85-3517-48DA-8BEC-1C722A1A7041Q30451626-4535446D-9C21-4F55-8A3D-5B6030EB4511Q33471115-1AD76BF3-A9E6-4A06-BBD4-863E959F1C11Q33746440-1332930E-9A8F-43E0-8053-9F861C9DD996Q34711495-3ECCBE38-E69C-4574-BE12-7DE559B4AD49Q35248808-39027F2F-A215-4893-B2E1-224922BC0D5BQ35289754-B0C3AFE9-C798-4F0B-A1A8-EA715F7BEBECQ35842862-97E7C0B4-E205-4BC8-9D22-F99C4DFF3098Q36140868-54C76B9D-4B34-4D30-8A60-6BDAD2517AA1Q36472531-9A49D2FA-9537-4902-915B-5F88D96D1762Q36481354-6D8EB3CF-9568-4146-8691-AF8AC1ED5BB1Q39815649-12123A8B-B599-4C97-88F4-D11B6FF16EB5Q39828400-2868DA57-80D5-4D01-9FCA-0B29D8914741Q39828423-05ACAEAF-AC88-43A5-92CF-A4A06E87C74BQ39832345-8FD394E8-609A-4997-B6A3-3C017903CE6BQ39851155-CF21B952-F8FD-4FB0-81D9-7B4CCD8EF038Q40286255-53BE6099-5A2D-481B-AFF6-8F56CEE58431Q42929997-19565F28-3FCF-4737-A7B2-8074D52195DAQ48590601-3AC22D1A-3E5C-4F68-AFFE-3A5CE2334A62
P2860
Cefaclor: in vitro spectrum of activity and beta-lactamase stability.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Cefaclor: in vitro spectrum of activity and beta-lactamase stability.
@en
type
label
Cefaclor: in vitro spectrum of activity and beta-lactamase stability.
@en
prefLabel
Cefaclor: in vitro spectrum of activity and beta-lactamase stability.
@en
P2860
P356
P1476
Cefaclor: in vitro spectrum of activity and beta-lactamase stability.
@en
P2860
P304
P356
10.1128/AAC.13.4.584
P407
P577
1978-04-01T00:00:00Z